Page last updated: 2024-08-17

hydroxyproline and osteoprotegerin

hydroxyproline has been researched along with osteoprotegerin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blat, D; Komosińska-Vassev, K; Olczyk, K; Olczyk, P	1
Cui, W; Du, H; Hao, J; Liu, D; Liu, F; Lu, J; Yang, X	1

Reviews

1 review(s) available for hydroxyproline and osteoprotegerin

Article	Year
[Osteoporosis--pathophysiology and laboratory diagnostic methods]. Przeglad lekarski, 2010, Volume: 67, Issue:7 Topics: Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Calcium; Collagen Type I; Female; Fractures, Bone; Humans; Hydroxyproline; Male; Osteoporosis; Osteoprotegerin; Parathyroid Hormone; Risk Factors; Vitamin D	2010

Other Studies

1 other study(ies) available for hydroxyproline and osteoprotegerin

Article	Year
Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. Experimental biology and medicine (Maywood, N.J.), 2016, Volume: 241, Issue:11 Topics: Administration, Oral; Amlodipine; Animals; Antihypertensive Agents; Atorvastatin; Cardiomegaly; Cross-Sectional Studies; Disease Models, Animal; Gene Expression Profiling; Hydroxyproline; Hypertension; Immunohistochemistry; Male; Myocardium; NF-kappa B; Osteoprotegerin; RANK Ligand; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Ventricular Function, Left	2016

Article

Year

Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats.

Experimental biology and medicine (Maywood, N.J.), 2016, Volume: 241, Issue:11

Topics: Administration, Oral; Amlodipine; Animals; Antihypertensive Agents; Atorvastatin; Cardiomegaly; Cross-Sectional Studies; Disease Models, Animal; Gene Expression Profiling; Hydroxyproline; Hypertension; Immunohistochemistry; Male; Myocardium; NF-kappa B; Osteoprotegerin; RANK Ligand; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Ventricular Function, Left

2016